Have your own idea? Try our Stock Screener
Australian (ASX) Healthcare Sector Analysis
UpdatedFeb 02, 2026
DataAggregated Company Financials
Companies125
- 7D-0.7%
- 3M-3.4%
- 1Y-28.6%
- YTD-0.05%
In the last week, the Healthcare industry is flat overall, with 4DMedical standing out by going down 22%. As for the longer term, the industry has declined 29% in the last year. Earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 02 Feb 2026 | AU$215.0b | AU$72.8b | AU$4.3b | 31.9x | 49.6x | 3x |
| Wed, 31 Dec 2025 | AU$214.3b | AU$73.8b | AU$4.5b | 33x | 47.6x | 2.9x |
| Fri, 28 Nov 2025 | AU$227.0b | AU$74.6b | AU$4.6b | 31.9x | 49.2x | 3x |
| Sun, 26 Oct 2025 | AU$243.8b | AU$74.9b | AU$4.6b | 30.6x | 52.9x | 3.3x |
| Tue, 23 Sep 2025 | AU$238.6b | AU$74.5b | AU$4.6b | 31.8x | 52.3x | 3.2x |
| Thu, 21 Aug 2025 | AU$248.6b | AU$71.1b | AU$5.3b | 26.1x | 47.1x | 3.5x |
| Sat, 19 Jul 2025 | AU$270.7b | AU$71.7b | AU$4.3b | 29.6x | 63.4x | 3.8x |
| Mon, 16 Jun 2025 | AU$254.7b | AU$71.8b | AU$4.3b | 25.8x | 59.4x | 3.5x |
| Wed, 14 May 2025 | AU$254.2b | AU$70.6b | AU$4.9b | 27.2x | 52x | 3.6x |
| Fri, 11 Apr 2025 | AU$243.8b | AU$71.6b | AU$5.0b | 26.3x | 48.4x | 3.4x |
| Sun, 09 Mar 2025 | AU$261.1b | AU$71.1b | AU$4.9b | 28.9x | 53.1x | 3.7x |
| Tue, 04 Feb 2025 | AU$250.9b | AU$69.1b | AU$3.4b | 26.6x | 73.7x | 3.6x |
| Thu, 02 Jan 2025 | AU$244.6b | AU$69.1b | AU$3.4b | 25.4x | 72.2x | 3.5x |
| Sat, 30 Nov 2024 | AU$248.2b | AU$68.0b | AU$3.2b | 26.8x | 77.6x | 3.7x |
| Mon, 28 Oct 2024 | AU$242.2b | AU$67.6b | AU$3.1b | 26x | 77x | 3.6x |
| Wed, 25 Sep 2024 | AU$236.9b | AU$66.6b | AU$3.0b | 27.3x | 78.4x | 3.6x |
| Fri, 23 Aug 2024 | AU$243.5b | AU$64.2b | AU$3.2b | 36.7x | 77.1x | 3.8x |
| Sun, 21 Jul 2024 | AU$244.6b | AU$62.7b | AU$2.6b | 33.1x | 93.8x | 3.9x |
| Tue, 18 Jun 2024 | AU$232.2b | AU$63.2b | AU$2.7b | 32.5x | 87.4x | 3.7x |
| Thu, 16 May 2024 | AU$227.0b | AU$61.1b | AU$2.6b | 26.5x | 87x | 3.7x |
| Sat, 13 Apr 2024 | AU$223.9b | AU$61.7b | AU$2.7b | 25.8x | 83.6x | 3.6x |
| Mon, 11 Mar 2024 | AU$225.8b | AU$61.4b | AU$2.6b | 25.7x | 86.5x | 3.7x |
| Wed, 07 Feb 2024 | AU$230.6b | AU$59.3b | AU$3.1b | 25.4x | 75.4x | 3.9x |
| Fri, 05 Jan 2024 | AU$224.3b | AU$60.0b | AU$2.8b | 24.9x | 80.8x | 3.7x |
| Sun, 03 Dec 2023 | AU$206.4b | AU$60.1b | AU$2.8b | 24.8x | 73.1x | 3.4x |
| Tue, 31 Oct 2023 | AU$184.6b | AU$61.2b | AU$3.0b | 24x | 61.9x | 3x |
| Thu, 28 Sep 2023 | AU$200.9b | AU$61.3b | AU$2.9b | 24.9x | 68.4x | 3.3x |
| Sat, 26 Aug 2023 | AU$207.7b | AU$61.5b | AU$2.9b | 24.9x | 71.1x | 3.4x |
| Mon, 24 Jul 2023 | AU$212.2b | AU$57.5b | AU$2.9b | 27x | 74.1x | 3.7x |
| Wed, 21 Jun 2023 | AU$221.4b | AU$57.4b | AU$2.8b | 25.7x | 78x | 3.9x |
| Fri, 19 May 2023 | AU$230.4b | AU$57.8b | AU$2.9b | 27.7x | 79.8x | 4x |
| Sun, 16 Apr 2023 | AU$231.5b | AU$57.1b | AU$2.9b | 28.5x | 80.9x | 4.1x |
| Tue, 14 Mar 2023 | AU$218.5b | AU$57.2b | AU$2.9b | 24.9x | 75.9x | 3.8x |
| Thu, 09 Feb 2023 | AU$229.8b | AU$55.1b | AU$3.9b | 24.9x | 58.5x | 4.2x |
Price to Earnings Ratio
58.5x
Current Industry PE
- Investors are pessimistic on the Australian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 49.6x which is lower than its 3-year average PE of 69.8x.
- The 3-year average PS ratio of 3.6x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 3.3% per year over the last three years.
- Revenues for these companies have grown 9.7% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | -0.40% | |
| Healthcare | -0.65% | |
| Biotech | 0.11% | |
| Healthcare Services | -0.019% | |
| Healthtech | -1.51% | |
| Medical Equipment | -2.47% | |
| Pharma | -7.30% | |
| Life Sciences | -13.55% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 2kx.
- Analysts are expecting annual earnings growth of 25.2%, which is lower than the prior year's growth of 62.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 70% over the next 5 years.
- This is better than its past earnings growth rate of 2.4% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CSL CSL | AU$181.42 | 1.0% +AU$867.8m | -35.3% | PE20.3x | |
| SIG Sigma Healthcare | AU$3.09 | 1.0% +AU$345.0m | n/a | PE67.1x | |
| PME Pro Medicus | AU$184.12 | 1.8% +AU$334.3m | -33.9% | PE166.9x | |
| CYC Cyclopharm | AU$1.17 | 33.0% +AU$32.2m | -47.3% | PS4.2x | |
| ACL Australian Clinical Labs | AU$2.73 | 3.0% +AU$15.3m | -27.2% | PE16.1x |
